Evidence map›Paper›PMID 40465118›Full record

ArticleMolecular imaging and biology2025

Evaluation of

Yumiko Kono, Keita Utsunomiya, Takahiro Shiraishi, Naoki Kan, Ichiro Shiojima, Kaoru Maruyama, Noboru Tanigawa

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecular imaging and biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yumiko KonoDepartment of Radiology, Kansai Medical University, 2-5-1 Shin-Machi, Hirakata City, Osaka, 573-1010, Japan. kono.yum@kmu.ac.jp.ORCID 0000-0002-7977-0272
Keita UtsunomiyaDepartment of Radiology, Kansai Medical University, 2-5-1 Shin-Machi, Hirakata City, Osaka, 573-1010, Japan.
Takahiro ShiraishiRadioisotope Research Center, Kansai Medical University, 2-5-1 Shin-Machi, Hirakata City, Osaka, 573-1010, Japan.
Naoki KanDepartment of Radiology, Sumitomo Hospital, 5-3-20 Nakanoshima, Kitaku, Osaka City, Osaka, 530-0005, Japan.
Ichiro ShiojimaRadioisotope Research Center, Kansai Medical University, 2-5-1 Shin-Machi, Hirakata City, Osaka, 573-1010, Japan.
Kaoru MaruyamaDepartment of Radiology, Kansai Medical University, 2-5-1 Shin-Machi, Hirakata City, Osaka, 573-1010, Japan.
Noboru TanigawaDepartment of Radiology, Kansai Medical University, 2-5-1 Shin-Machi, Hirakata City, Osaka, 573-1010, Japan.

Funding

MEXT KAKENHI JP21K15561
6 · The paper itself

Abstract

backgroundLutetium-177 (

methodsAfter synthesizing

resultsThe

conclusion

Indexed as

Carcinoma, HepatocellularEthiodized OilLiver NeoplasmsLutetiumRadioisotopesXenograft Model Antitumor AssaysAnimalsCell Line, TumorHumansMaleRatsRats, Inbred F344Single Photon Emission Computed Tomography Computed TomographyTissue DistributionEthiodized OilLutetiumLutetium-177RadioisotopesBiodistributionHepatocellular carcinomaLipiodolLutetium-177Radionuclide therapySPECT imagingTheranosticsTumor growth suppression

Identifiers

PMID40465118
PMCPMC12405020

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.